<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31879754</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011-2018: A Longitudinal Surveillance Study.</ArticleTitle><Pagination><StartPage>3088</StartPage><EndPage>3095</EndPage><MedlinePgn>3088-3095</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciz1188</ELocationID><Abstract><AbstractText Label="BACKGROUND">Enterovirus 71 (EV71) is a major causative agent of hand, foot, and mouth disease (HFMD), associated with severe manifestations of the disease. Pediatric immunization with inactivated EV71 vaccine was initiated in 2016 in the Asia-Pacific region, including China. We analyzed a time series of HFMD cases attributable to EV71, coxsackievirus A16 (CA16), and other enteroviruses in Chengdu, a major transmission center in China, to assess early impacts of immunization.</AbstractText><AbstractText Label="METHODS">Reported HFMD cases were obtained from China's notifiable disease surveillance system. We compared observed postvaccination incidence rates during 2017-2018 with counterfactual predictions made from a negative binomial regression and a random forest model fitted to prevaccine years (2011-2015). We fit a change point model to the full time series to evaluate whether the trend of EV71 HFMD changed following vaccination.</AbstractText><AbstractText Label="RESULTS">Between 2011 and 2018, 279 352 HFMD cases were reported in the study region. The average incidence rate of EV71 HFMD in 2017-2018 was 60% (95% prediction interval [PI], 41%-72%) lower than predicted in the absence of immunization, corresponding to an estimated 6911 (95% PI, 3246-11 542) EV71 cases averted over 2 years. There were 52% (95% PI, 42%-60%) fewer severe HFMD cases than predicted. However, the incidence rate of non-CA16 and non-EV71 HFMD was elevated in 2018. We identified a significant decline in the trend of EV71 HFMD 4 months into the postvaccine period.</AbstractText><AbstractText Label="CONCLUSIONS">We provide the first real-world evidence that programmatic vaccination against EV71 is effective against childhood HFMD and present an approach to detect early vaccine impact or intended consequences from surveillance data.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Head</LastName><ForeName>Jennifer R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collender</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewnard</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skaff</LastName><ForeName>Nicholas K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Public Health Information, Sichuan Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Qu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Julia M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dehao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohringer</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Changhong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Public Health Information, Sichuan Center for Disease Control and Prevention, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hubbard</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopman</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remais</LastName><ForeName>Justin V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI125842</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 TW010286</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">hand, foot, and mouth disease</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31879754</ArticleId><ArticleId IdType="pmc">PMC7819528</ArticleId><ArticleId IdType="doi">10.1093/cid/ciz1188</ArticleId><ArticleId IdType="pii">5687873</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Health Commission of the People&#x2019;s Republic of China. Report on notifiable diseases. Available at: http://www.nhc.gov.cn/. Accessed 3 September 2019.</Citation></Reference><Reference><Citation>Yang B, Liu F, Liao Q, et al. &#xa0;Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill 2017; 22:16-00824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743100</ArticleId><ArticleId IdType="pubmed">29258646</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wu J, Ding C, et al. &#xa0;Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis 2017; 17:716&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164789</ArticleId><ArticleId IdType="pubmed">28412150</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. &#xa0;Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis 2014; 14:308&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther 2015; 13:1061&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo K, Gao L, Zou G, et al. &#xa0;Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples. Clin Infect Dis 2018; 67:1729&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">29688329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji T, Han T, Tan X, et al. &#xa0;Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosaf Health 2019; 1:32&#x2013;40.</Citation></Reference><Reference><Citation>Zheng Y, Jit M, Wu JT, et al. &#xa0;Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China. PLoS One 2017; 12:e0184266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608208</ArticleId><ArticleId IdType="pubmed">28934232</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines 2016; 15:599&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, et al. &#xa0;An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014; 370:829&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, et al. &#xa0;Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014; 370:818&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M, Meng F, Wang S, et al. &#xa0;2-year efficacy, immunogenicity, and safety of Vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study. J Infect Dis 2017; 215:56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28077584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, et al. &#xa0;Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381:2024&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>
Xinhua. Hand, foot and mouth disease on rise in Beijing. 2018.  Available at: http://www.chinadaily.com.cn/a/201807/04/WS5b3c6e64a3103349141e0a93.html. Accessed 3 September 2019.</Citation></Reference><Reference><Citation>Zhang J. Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008&#x2013;2017. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40:147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30744263</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Liao Q, Van Boeckel TP, et al. &#xa0;Hand, foot, and mouth disease in china: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Med 2016; 13:e1001958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755668</ArticleId><ArticleId IdType="pubmed">26882540</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378:1962&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256741</ArticleId><ArticleId IdType="pubmed">21492929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro GS, Reis JN, Cordeiro SM, et al. &#xa0;Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003; 187:109&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">12508153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhao X, Yin F, Lv Q. Spatio-temporal clustering of hand, foot and mouth disease at the county level in Sichuan province, China, 2008&#x2013;2013. Epidemiol Infect 2015; 143:831&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9507101</ArticleId><ArticleId IdType="pubmed">25703402</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistical Bureau of Sichuan Sichuan statistical yearbook 2012&#x2013;2018. Beijing: China Statistics Press, 2018.</Citation></Reference><Reference><Citation>Wang J, Cao Z, Zeng DD, Wang Q, Wang X, Qian H. Epidemiological analysis, detection, and comparison of space-time patterns of Beijing hand-foot-mouth disease (2008&#x2013;2012). PLoS One 2014; 9:e92745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963949</ArticleId><ArticleId IdType="pubmed">24663329</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Li Z, Lan Y, et al. &#xa0;A nationwide web-based automated system for outbreak early detection and rapid response in China. Western Pac Surveill Response J 2011; 2:10&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729055</ArticleId><ArticleId IdType="pubmed">23908878</ArticleId></ArticleIdList></Reference><Reference><Citation>China Center for Disease Control and Prevention. Guideline of HFMD diagnosis and treatment in 2008. Beijing: China Center for Disease Control and Prevention, 2009.</Citation></Reference><Reference><Citation>Oma&#xf1;a-Cepeda C, Mart&#xed;nez-Valverde A, del Mar Sabater-Recolons M, Jan&#xe9;-Salas E, Mar&#xed;-Roig A, L&#xf3;pez-L&#xf3;pez J. A literature review and case report of hand, foot and mouth disease in an immunocompetent adult. BMC Res Notes 2016; 9:165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791924</ArticleId><ArticleId IdType="pubmed">26975350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventarola D, Bordone L, Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol 2015; 33:340&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25889136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Feng Z, Yang Y, et al. &#xa0;Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology 2011; 22:781&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuck-Paim C, Taylor RJ, Alonso WJ, Weinberger DM, Simonsen L. Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study. Lancet Glob Health 2019; 7:e249&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344339</ArticleId><ArticleId IdType="pubmed">30683242</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA. Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the United States in 2000&#x2013;2013: analysis of a large hospital discharge data set. Clin Infect Dis 2018; 68:976&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182126</ArticleId><ArticleId IdType="pubmed">30020438</ArticleId></ArticleIdList></Reference><Reference><Citation>do Carmo GM, Yen C, Cortes J, et al. &#xa0;Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011; 8:e1001024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3079643</ArticleId><ArticleId IdType="pubmed">21526228</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmeir C, Ben&#xed;tez JM. On the use of cross-validation for time series predictor evaluation. Inf Sci 2012; 191:192&#x2013;213.</Citation></Reference><Reference><Citation>Roberts DR, Bahn V, Ciuti S, et al. &#xa0;Cross&#x2010;validation strategies for data with temporal, spatial, hierarchical, or phylogenetic structure. Ecography 2017; 40:913&#x2013;29.</Citation></Reference><Reference><Citation>Wright MN, Ziegler A. Ranger: a fast implementation of random forests for high dimensional data in C++ and R. J Stat Softw 2017; 77:1&#x2013;17.</Citation></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn 2011; 45:5&#x2013;32.</Citation></Reference><Reference><Citation>Meinshausen N. Quantile regression forests. J Mach Learn Res 2006; 7:983&#x2013;99.</Citation></Reference><Reference><Citation>K&#xfc;r&#xfc;m E, Warren JL, Schuck-Paim C, et al. &#xa0;Bayesian model averaging with change points to assess the impact of vaccination and public health interventions. Epidemiology 2017; 28:889&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617796</ArticleId><ArticleId IdType="pubmed">28767518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 2017; 46:348&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407170</ArticleId><ArticleId IdType="pubmed">27283160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Song J, Wang J, et al. &#xa0;Cost-effectiveness of a national enterovirus 71 vaccination program in China. PLoS Negl Trop Dis 2017; 11:e0005899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608421</ArticleId><ArticleId IdType="pubmed">28892475</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Metcalf CJE, Arima Y, et al. &#xa0;Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan. J R Soc Interface 2018; 15. doi:10.1098/rsif.2018.0507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170776</ArticleId><ArticleId IdType="pubmed">30209044</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki S, Shima M, Yamamoto K. Spatiotemporal land use random forest model for estimating metropolitan NO2 exposure in Japan. Sci Total Environ 2018; 634:1269&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">29710628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>